Table of Contents Author Guidelines Submit a Manuscript
Advances in Urology
Volume 2008, Article ID 413505, 7 pages
http://dx.doi.org/10.1155/2008/413505
Review Article

Familial Syndromes Coupling with Small Renal Masses

Department of Urology, Instituto Medico Tecnológico, Barcelona 08024, Spain

Received 27 March 2008; Accepted 2 July 2008

Academic Editor: J. Rubio

Copyright © 2008 Jorge Hidalgo and Gilberto Chéchile. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. B. Zbar, R. Klausner, and W. M. Linehan, “Studying cancer families to identify kidney cancer genes,” Annual Review of Medicine, vol. 54, pp. 217–233, 2003. View at Publisher · View at Google Scholar · View at PubMed
  2. W. M. Linehan, M. M. Walther, and B. Zbar, “The genetic basis of cancer of the kidney,” The Journal of Urology, vol. 170, no. 6, part 1, pp. 2163–2172, 2003. View at Publisher · View at Google Scholar · View at PubMed
  3. B. Zbar, G. Glenn, M. Merino et al., “Familial renal carcinoma: clinical evaluation, clinical subtypes and risk of renal carcinoma development,” The Journal of Urology, vol. 177, no. 2, pp. 461–465, 2007. View at Publisher · View at Google Scholar · View at PubMed
  4. G. Kovacs, M. Akhtar, B. J. Beckwith et al., “The Heidelberg classification of renal cell tumours,” The Journal of Pathology, vol. 183, no. 2, pp. 131–133, 1997. View at Publisher · View at Google Scholar
  5. L. Schmidt, F.-M. Duh, F. Chen et al., “Germline and somatic mutations in the tyrosine kinase domain of the MET proto-oncogene in papillary renal carcinomas,” Nature Genetics, vol. 16, no. 1, pp. 68–73, 1997. View at Publisher · View at Google Scholar · View at PubMed
  6. V. Launonen, O. Vierimaa, M. Kiuru et al., “Inherited susceptibility to uterine leiomyomas and renal cell cancer,” Proceedings of the National Academy of Sciences of the United States of America, vol. 98, no. 6, pp. 3387–3392, 2001. View at Publisher · View at Google Scholar · View at PubMed
  7. B. R. Lane, M. K. Samplaski, B. R. Herts, M. Zhou, A. C. Novick, and S. C. Campbell, “Renal mass biopsy—a renaissance?,” The Journal of Urology, vol. 179, no. 1, pp. 20–27, 2008. View at Publisher · View at Google Scholar · View at PubMed
  8. I. Zeltser and J. A. Cadeddu, “The aggressive potential of small renal tumors,” Nature Clinical Practice Urology, vol. 4, no. 3, pp. 124–125, 2007. View at Publisher · View at Google Scholar · View at PubMed
  9. R. L. Grubb, III, P. L. Choyke, P. A. Pinto, W. M. Linehan, and M. M. Walther, “Management of von Hippel-Lindau-associated kidney cancer,” Nature Clinical Practice Urology, vol. 2, no. 5, pp. 248–255, 2005. View at Publisher · View at Google Scholar · View at PubMed
  10. J. C. Herring, E. G. Enquist, A. Chernoff, W. M. Linehan, P. L. Choyke, and M. M. Walther, “Parenchymal sparing surgery in patients with hereditary renal cell carcinoma: 10-year experience,” The Journal of Urology, vol. 165, no. 3, pp. 777–781, 2001. View at Publisher · View at Google Scholar
  11. M. M. Walther, I. A. Lubensky, D. Venzon, B. Zbar, and W. M. Linehan, “Prevalence of microscopic lesions in grossly normal renal parenchyma from patients with von Hippel-Lindau disease, sporadic renal cell carcinoma and no renal disease: clinical implications,” The Journal of Urology, vol. 154, no. 6, pp. 2010–2015, 1995. View at Publisher · View at Google Scholar
  12. F. Latif, K. Tory, J. Gnarra et al., “Identification of the von Hippel-Lindau disease tumor suppressor gene,” Science, vol. 260, no. 5112, pp. 1317–1320, 1993. View at Publisher · View at Google Scholar
  13. W. G. Kaelin, Jr., “The von Hippel-Lindau tumor suppressor gene and kidney cancer,” Clinical Cancer Research, vol. 10, no. 18, pp. 6290S–6295S, 2004. View at Publisher · View at Google Scholar · View at PubMed
  14. M. M. Walther, P. L. Choyke, G. Glenn et al., “Renal cancer in families with hereditary renal cancer: prospective analysis of a tumor size threshold for renal parenchymal sparing surgery,” The Journal of Urology, vol. 161, no. 5, pp. 1475–1479, 1999. View at Publisher · View at Google Scholar
  15. A. C. Novick and S. B. Streem, “Long-term followup after nephron sparing surgery for renal cell carcinoma in von Hippel-Lindau disease,” The Journal of Urology, vol. 147, no. 6, pp. 1488–1490, 1992. View at Google Scholar
  16. D. A. Goldfarb, H. P. H. Neumann, I. Penn, and A. C. Novick, “Results of renal transplantation in patients with renal cell carcinoma and von Hippel-Lindau disease,” Transplantation, vol. 64, no. 12, pp. 1726–1729, 1997. View at Publisher · View at Google Scholar
  17. M. Frydenberg, R. S. Malek, and H. Zincke, “Conservative renal surgery for renal cell carcinoma in von Hippel-Lindau's disease,” The Journal of Urology, vol. 149, no. 3, pp. 461–464, 1993. View at Google Scholar
  18. G. Bratslavsky, J. J. Liu, A. D. Johnson et al., “Salvage partial nephrectomy for hereditary renal cancer: feasibility and outcomes,” The Journal of Urology, vol. 179, no. 1, pp. 67–70, 2008. View at Publisher · View at Google Scholar · View at PubMed
  19. B. G. Duffey, P. L. Choyke, G. Glenn et al., “The relationship between renal tumor size and metastases in patients with von Hippel-Lindau disease,” The Journal of Urology, vol. 172, no. 1, pp. 63–65, 2004. View at Publisher · View at Google Scholar · View at PubMed
  20. B. Delahunt and J. N. Eble, “Papillary renal cell carcinoma: a clinicopathologic and immunohistochemical study of 105 tumors,” Modern Pathology, vol. 10, no. 6, pp. 537–544, 1997. View at Google Scholar
  21. B. Zbar, G. Glenn, I. Lubensky et al., “Hereditary papillary renal cell carcinoma: clinical studies in 10 families,” The Journal of Urology, vol. 153, no. 3, supplement 1, pp. 907–912, 1995. View at Publisher · View at Google Scholar
  22. P. L. Choyke, G. M. Glenn, M. M. Walther, B. Zbar, and W. M. Linehan, “Hereditary renal cancers,” Radiology, vol. 226, no. 1, pp. 33–46, 2003. View at Publisher · View at Google Scholar
  23. L. S. Schmidt, M. L. Nickerson, D. Angeloni et al., “Early onset hereditary papillary renal carcinoma: germline missense mutations in the tyrosine kinase domain of the MET proto-oncogene,” The Journal of Urology, vol. 172, no. 4, part 1, pp. 1256–1261, 2004. View at Publisher · View at Google Scholar
  24. S. K. Khoo, S. Giraud, K. Kahnoski et al., “Clinical and genetic studies of Birt-Hogg-Dubé syndrome,” Journal of Medical Genetics, vol. 39, no. 12, pp. 906–912, 2002. View at Publisher · View at Google Scholar
  25. B. Zbar, W. G. Alvord, G. Glenn et al., “Risk of renal and colonic neoplasms and spontaneous pneumothorax in the Birt-Hogg-Dubé syndrome,” Cancer Epidemiology Biomarkers & Prevention, vol. 11, no. 4, pp. 393–400, 2002. View at Google Scholar
  26. C. P. Pavlovich, M. M. Walther, R. A. Eyler et al., “Renal tumors in the Birt-Hogg-Dubé syndrome,” American Journal of Surgical Pathology, vol. 26, no. 12, pp. 1542–1552, 2002. View at Publisher · View at Google Scholar
  27. M. L. Nickerson, M. B. Warren, J. R. Toro et al., “Mutations in a novel gene lead to kidney tumors, lung wall defects, and benign tumors of the hair follicle in patients with the Birt-Hogg-Dubé syndrome,” Cancer Cell, vol. 2, no. 2, pp. 157–164, 2002. View at Publisher · View at Google Scholar
  28. C. P. Pavlovich, R. L. Grubb, III, K. Hurley et al., “Evaluation and management of renal tumors in the Birt-Hogg-Dubé syndrome,” The Journal of Urology, vol. 173, no. 5, pp. 1482–1486, 2005. View at Publisher · View at Google Scholar · View at PubMed
  29. C. D. Vocke, Y. Yang, C. P. Pavlovich et al., “High frequency of somatic frameshift BHD gene mutations in Birt-Hogg-Dubé—associated renal tumors,” Journal of the National Cancer Institute, vol. 97, no. 12, pp. 931–935, 2005. View at Publisher · View at Google Scholar · View at PubMed
  30. I. P. M. Tomlinson, N. A. Alam, A. J. Rowan et al., “Germline mutations in FH predispose to dominantly inherited uterine fibroids, skin leiomyomata and papillary renal cell cancer,” Nature Genetics, vol. 30, no. 4, pp. 406–410, 2002. View at Publisher · View at Google Scholar · View at PubMed
  31. J. R. Toro, M. L. Nickerson, M.-H. Wei et al., “Mutations in the fumarate hydratase gene cause hereditary leiomyomatosis and renal cell cancer in families in North America,” The American Journal of Human Genetics, vol. 73, no. 1, pp. 95–106, 2003. View at Publisher · View at Google Scholar · View at PubMed
  32. R. L. Grubb, III, M. E. Franks, J. Toro et al., “Hereditary leiomyomatosis and renal cell cancer: a syndrome associated with an aggressive form of inherited renal cancer,” The Journal of Urology, vol. 177, no. 6, pp. 2074–2080, 2007. View at Publisher · View at Google Scholar · View at PubMed
  33. H. P. H. Neumann, C. Pawlu, M. Pęczkowska et al., “Distinct clinical features of paraganglioma syndromes associated with SDHB and SDHD and gene mutations,” The Journal of the American Medical Association, vol. 292, no. 8, pp. 943–951, 2004. View at Publisher · View at Google Scholar · View at PubMed